Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Acquir Immune Defic Syndr ; 75(2): 156-163, 2017 Jun 01.
Article in English | MEDLINE | ID: mdl-28234689

ABSTRACT

INTRODUCTION: Management of tuberculosis (TB) is challenging in HIV/TB-coinfected children. The World Health Organization recommends nucleic acid amplification tests for TB diagnosis, a 4-drug regimen including ethambutol during intensive phase (IP) of treatment, and initiation of antiretroviral therapy (ART) within 8 weeks of TB diagnosis. We investigated TB treatment outcomes by diagnostic modality, IP regimen, and ART status. METHODS: We conducted a retrospective cohort study among HIV/TB-coinfected children enrolled at the International Epidemiology Databases to Evaluate AIDS treatment sites from 2012 to 2014. We modeled TB outcome using multivariable logistic regression including diagnostic modality, IP regimen, and ART status. RESULTS: Among the 386 HIV-infected children diagnosed with TB, 20% had microbiologic confirmation of TB, and 20% had unfavorable TB outcomes. During IP, 78% were treated with a 4-drug regimen. Thirty-one percent were receiving ART at the time of TB diagnosis, and 32% were started on ART within 8 weeks of TB diagnosis. Incidence of ART initiation within 8 weeks of TB diagnosis was higher for those with favorable TB outcomes (64%) compared with those with unfavorable outcomes (40%) (P = 0.04). Neither diagnostic modality (odds ratio 1.77; 95% confidence interval: 0.86 to 3.65) nor IP regimen (odds ratio 0.88; 95% confidence interval: 0.43 to 1.80) was associated with TB outcome. DISCUSSION: In this multinational study of HIV/TB-coinfected children, many were not managed as per World Health Organization guidelines. Children with favorable TB outcomes initiated ART sooner than children with unfavorable outcomes. These findings highlight the importance of early ART for children with HIV/TB coinfection, and reinforce the need for implementation research to improve pediatric TB management.


Subject(s)
Anti-HIV Agents/therapeutic use , Antitubercular Agents/therapeutic use , Coinfection/drug therapy , Databases, Factual , HIV Infections/drug therapy , Tuberculosis/drug therapy , Africa South of the Sahara/epidemiology , Asia, Southeastern/epidemiology , CD4 Lymphocyte Count , Child , Child, Preschool , Coinfection/epidemiology , Female , HIV Infections/epidemiology , Humans , Infant , Male , Proportional Hazards Models , Retrospective Studies , Treatment Outcome , Tuberculosis/epidemiology , Viral Load , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL
...